JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
77,450
-27,379
-16,443
-13,703
-30,611
Depreciation & amortization
3,870
3,831
4,422
1,944
1,470
Deferred income taxes
-
-
-
-
-
Stock based compensation
9,788
9,407
4,775
4,989
1,352
Change in working capital
-120,331
-48,365
-84,739
186,131
1,830
Accounts receivable
-
-
-
-
-
Inventory
-
-
-
-
-
Accounts Payable
498
562
373
-312
673
Other working capital
-32,187
-64,972
-105,845
177,466
-27,941
Other non-cash items
-
-
-
5,316
-1,859
Net cash provided by operating activites
-30,968
-63,613
-90,738
179,688
-25,739
Cash flows from investing activities
Investments in property, plant and equipment
-1,219
-1,359
-15,107
-2,222
-2,202
Acquisitions, net
-
-
-
-
-
Purchases of investments
-206,214
-252,918
-179,874
-213,286
0
Sales/Maturities of investments
250,928
340,691
156,960
-
-
Other investing activites
-
-
-
0
60
Net cash used for investing activites
43,495
86,414
-38,021
-215,508
-2,142
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
-
0
107,008
50
112
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-
-
-620
-241
Net cash used privided by (used for) financing activities
592
1,546
107,470
35,507
70,704
Net change in cash
13,119
24,347
-21,289
-313
42,823
Cash at beginning of period
54,553
24,829
44,848
45,161
2,338
Cash at end of period
67,672
49,176
23,559
44,848
45,161
Free Cash Flow
Operating Cash Flow
-30,968
-63,613
-90,738
179,688
-25,739
Capital Expenditure
-1,219
-1,359
-15,107
-2,222
-2,202
Free Cash Flow
-32,187
-64,972
-105,845
177,466
-27,941